SSlabIndex
Signal RoomGraded MarketMorning BriefTrack RecordPortfolioPricing
SSlabIndex™

Every card scored — raw and graded. Every opportunity tracked. Public results.

Newsletter

Best cards and slabs to invest in this week, every Monday.

Free. Mondays. Unsubscribe in one click.

Market
  • Signal Room
  • Graded Market
  • Morning Brief
  • Track Record
  • Best cards to grade
  • Newsletter
Account
  • Portfolio
  • Pricing
  • Log in
  • Create account
Company
  • About
  • vs PriceCharting
  • Terms
  • Privacy
  • Refunds

SlabIndex publishes market analysis, not investment advice. Nothing here is a recommendation to buy or sell, no outcome is guaranteed, and past results — including every figure in the track record — do not predict future ones. Collectibles are illiquid and can lose value. Trade with money you can afford to lose.

Home/Pokémon (Japanese)/Forest of Vitality
Forest of Vitality
Hover to enlarge
Raw (NM)
$1.10
-19.7% 30d
PSA 10
$14
12.3× raw
▼▼Strong Sellmedium confidence

A model's opinion, not investment advice.

Forest of Vitality

Nihil Zero · 109 · スーパーレア · 2026

Raw 30d
-19.7%−$0.27
PSA 10 30d
+0.0%+$0.00
Our own tracked price, not sales
PSA 10 gem rate
71.2%
37 of 52 PSA submissions gemmed
Total graded
52
Copies with a published pop report
Raw sales · 30d
14
About 3.3 a week · PriceCharting, annual basis
Price history

What it has been worth

The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.

Forest of Vitality — raw market price
$1.10−20.3% 6M
$1.57$1.31$1.05
2026/04/092026/06/012026/07/072026/08/112026/09/30
Raw market price
142 points

Premium1 graded series can be laid over this line — see what the slab did while the raw price moved.Unlock

Graded market

Grade ladder & population report

Every graded price published, next to how many copies exist at that grade.

Raw (ungraded, near mint)
$1.10
30 day
-19.7%

PSA1 grade priced

52 certified in total
GradeMarketvs rawPopulationPop higher
▶PSA 10$13.50
12.3×
370

A model's opinion, not investment advice.